Standout Papers

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk... 2015 2026 2018 2022 340
  1. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial (2015)
    Alan K. Burnett, Nigel H. Russell et al. The Lancet Oncology

Immediate Impact

2 from Science/Nature 50 standout
Sub-graph 1 of 24

Citing Papers

Causes of death among people living with metastatic cancer
2024 Standout
Cancer statistics, 2024
2024 Standout
2 intermediate papers

Works of Gail Jones being referenced

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
2015 Standout
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma
2007

Author Peers

Author Last Decade Papers Cites
Gail Jones 734 267 537 275 30 1.4k
MA Goldberg 854 330 385 154 24 1.6k
F. Maloisel 570 215 378 108 61 1.2k
H Enright 657 186 311 90 30 1.3k
Marcos Rothstein 484 146 285 341 29 1.5k
Raúl G. Carlini 433 123 240 200 28 1.3k
P. Koistinen 340 239 305 81 41 1.1k
R H Herzig 630 322 159 172 27 1.1k
Andrew Will 782 328 322 203 53 1.6k
John J. Stuart 265 207 156 222 51 1.3k
Randy A. Brown 520 123 319 59 38 1.0k

All Works

Loading papers...

Rankless by CCL
2026